TAVR: Reasons to Consider Mitral Annular Calcification

Courtesy of Dr. Carlos Fava.

TAVR: Reasons to Consider Mitral Annular CalcificationAortic valve calcification and mitral annular calcification have the same etiology and are frequently present in high-risk patients undergoing transcatheter aortic valve replacement (TAVR). The implications of mitral annular calcification for patients undergoing TAVR has not been entirely clarified yet.

 

The study examined 782 patients with severe aortic stenosis who underwent TAVR. Among these patients, 375 (49.9%) presented mitral annular calcification in the computerized tomography scan:

  • Mild: 30.4%
  • Moderate: 9.5%
  • Severe: 9.5%

 

Patients who experienced the highest rate of mitral annular calcification were the eldest (83 vs. 81.9 years old), those with chronic renal insufficiency, and those with a higher Society of Thoracic Surgeons (STS) score (8.8 vs. 7.5; p <0,001).

 

Procedural success was similar for all patients, and no differences in mortality and major complications were observed at 30 daysAt 1 year, severe mitral annular calcification was found to be an independent predictor of all-cause mortality (hazard ratio [HR]: 1.95; 95% confidence interval [CI]: 1.24-3.07; p = 0.004) and cardiovascular mortality (HR: 2.35; 95% CI: 1.19-4.66; p = 0.01). Furthermore, it was an independent predictor of the need for a new permanent pacemaker after TAVR (odds ratio [OR]: 2.83; 95% CI: 1.08-7.47; p = 0.03).

 

Conclusion

Half of the patients with severe aortic stenosis experience mitral annular calcification. Severe mitral annular calcification is associated with increased all-cause and cardiovascular mortality, and with conduction disorders after TAVR. This pathology should be included in future risk stratification models.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Original title: Concomitant Mitral Annular Calcification and Severe Aortic Stenosis: Prevalence, Characteristics and Outcome Following Transcatheter Aortic Valve Replacement.

Reference: Yigal Abramowitz, et al. European Heart Journal Advance Access published December 30, 2016.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...

TAVR in Young Low-Risk Patients

Transcatheter aortic valve replacement (TAVR) has established itself as an effective strategy for the treatment of severe aortic stenosis across different risk groups. While previous...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...